Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study

OBJECTIVE: This study was undertaken to examine long‐term (up to 7.8 years) retention rate, safety, and tolerability of the antiseizure medication (ASM) cenobamate as adjunctive treatment in the open‐label extension (OLE) of study YKP3089C013 (C013; ClinicalTrials.gov: NCT01397968). METHODS: Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: French, Jacqueline A., Chung, Steve S., Krauss, Gregory L., Lee, Sang Kun, Maciejowski, Maciej, Rosenfeld, William E., Sperling, Michael R., Kamin, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456960/
https://www.ncbi.nlm.nih.gov/pubmed/34254673
http://dx.doi.org/10.1111/epi.17007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456960/
https://www.ncbi.nlm.nih.gov/pubmed/34254673
http://dx.doi.org/10.1111/epi.17007

Ejemplares similares